Abstract
In this article, we synthesized a series of novel 1-benzyl-5(3)-p-tolyl-1H-pyrazole-3(5)-carboxylic acid derivatives and characterized by IR, 1H NMR, and mass spectroscopy. Compounds were evaluated for their in vivo analgesic and anti-inflammatory activity using the p-benzoquinone-induced writhing test and the carrageenan-induced paw edema model, respectively. Out of 14 compounds tested, 7a, 7c, 7e, 7f, 7i, 8a–b, and 8f–g exhibited potent analgesic and/or anti-inflammatory activity as compared to reference drugs aspirin and indomethacin. Anticancer activity of these compounds was assessed against five cancer cell lines with the MTT assay (HL-60, human promyelocytic leukemia cells; HeLa, human cervical cancer cells; Raji, human B lymphocyte cell line; MCF7, human breast adenocarcinoma cell line; MDA-MB-231, estrogen-independent human breast cancer cell line). Compounds 7a, 8a, and 8b with high anti-inflammatory activity, and also 7d and 7j with mild anti-inflammatory activity exhibited promising anticancer activity against some selected cell lines.
Similar content being viewed by others
References
Agrawal A, Fentiman IS (2008) NSAIDs and breast cancer: a possible prevention and treatment strategy. Int J Clin Pract 62(3):444–449. doi:10.1111/j.1742-1241.2007.01668.x
Baker AK, Hoffmann VL, Meert TF (2002) Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain. Pharmacol Biochem Behav 74(1):73–86
Banoglu E, Okcelik B, Kupeli E, Unlu S, Yesilada E, Amat M, Caturla JF, Sahin MF (2003) Amide derivatives of [5-chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic acids as potential analgesic and anti-inflammatory compounds. Arch Pharm (Weinheim) 336(4–5):251–257. doi:10.1002/ardp.200300723
Banoglu E, Akoglu C, Unlu S, Kupeli E, Yesilada E, Sahin MF (2004) Amide derivatives of [6-(5-methyl-3-phenylpyrazole-1-yl)-3(2H)-pyridazinone-2-yl]acetic acids as potential analgesic and anti-inflammatory compounds. Arch Pharm (Weinheim) 337(1):7–14. doi:10.1002/ardp.200200738
Banoglu E, Akoglu C, Unlu S, Ergun BC, Kupeli E, Yesilada E, Sahin MF (2005) Synthesis of amide derivatives of [6-(3,5-dimethylpyrazol-1-yl)-3(2H)-pyridazinone-2-yl] acetic acid and their analgesic and anti-inflammatory properties. Arzneimittelforschung 55(9):520–527
Barthel HR, Axford-Gatley RA (2010) Topical nonsteroidal anti-inflammatory drugs for osteoarthritis. Postgrad Med 122(6):98–106. doi:10.3810/pgm.2010.11.2227
Bekhit AA, Hymete A, El-Din ABA, Damtew A, Aboul-Enein HY (2010) Pyrazoles as promising scaffold for the synthesis of anti-inflammatory and/or antimicrobial agent: a review. Mini Rev Med Chem 10(11):1014–1033
Bhalke RD, Chavan MJ (2011) Analgesic and CNS depressant activities of extracts of Annona reticulata Linn bark. Phytopharmacology 1(5):160–165
Caliskan B, Luderer S, Ozkan Y, Werz O, Banoglu E (2011) Pyrazol-3-propanoic acid derivatives as novel inhibitors of leukotriene biosynthesis in human neutrophils. Eur J Med Chem 46(10):5021–5033. doi:10.1016/j.ejmech.2011.08.009
Chao SH, Wu AB, Lee CJ, Chen FA, Wang CC (2005) Anti-inflammatory effects of indomethacin’s methyl ester derivative and induction of apoptosis in HL-60 Cells. Biol Pharm Bull 28(12):2206–2210
Charo IF, Taub R (2011) Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov 10(5):365–376. doi:10.1038/nrd3444
Claria J, Romano M (2005) Pharmacological intervention of cyclooxygenase-2 and 5-lipoxygenase pathways. Impact on inflammation and cancer. Curr Pharm Des 11(26):3431–3447
Ding XL, Zhang HY, Qi L, Zhao BX, Lian S, Lv HS, Miao JY (2009) Synthesis of novel pyrazole carboxamide derivatives and discovery of modulators for apoptosis or autophagy in A549 lung cancer cells. Bioorg Med Chem Lett 19(18):5325–5328. doi:10.1016/j.bmcl.2009.07.131
Ergun BC, Nunez MT, Labeaga L, Ledo F, Darlington J, Bain G, Cakir B, Banoglu E (2010) Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation. Arzneimittelforschung 60(8):497–505
Farag AM, Ali KA, El-Debss TM, Mayhoub AS, Amr AG, Abdel-Hafez NA, Abdulla MM (2010) Design, synthesis and structure-activity relationship study of novel pyrazole-based heterocycles as potential antitumor agents. Eur J Med Chem 45(12):5887–5898. doi:10.1016/j.ejmech.2010.09.054
Fischer SM, Hawk ET, Lubet RA (2011) Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila) 4(11):1728–1735. doi:10.1158/1940-6207.CAPR-11-0166
Ghosh J, Myers CE (1997) Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235(2):418–423. doi:10.1006/bbrc.1997.6799
Ghosh J, Myers CE (1998) Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci USA 95(22):13182–13187
Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, Kaidi A (2009) The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 30(3):377–386. doi:10.1093/carcin/bgp014
Grossman EM, Longo WE, Panesar N, Mazuski JE, Kaminski DL (2000) The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells. Carcinogenesis 21(7):1403–1409
Gupta LK, Bansal U, Chandra S (2007) Spectroscopic and physicochemical studies on nickel(II) complexes of isatin-3,2′-quinolyl-hydrazones and their adducts. Spectrochim Acta A 66:972–975
Heneka MT, Kummer MP, Weggen S, Bulic B, Multhaup G, Munter L, Hull M, Pflanzner T, Pietrzik CU (2011) Molecular mechanisms and therapeutic application of NSAIDs and derived compounds in Alzheimer’s disease. Curr Alzheimer Res 8(2):115–131
Kasahara Y, Hikino H, Tsurufuji S, Watanabe M, Ohuchi K (1985) Antiinflammatory actions of ephedrines in acute inflammations1. Planta Med 51(4):325–331. doi:10.1055/s-2007-969503
Keter FK, Darkwa J (2011) Perspective: the potential of pyrazole-based compounds in medicine. Biometals. doi:10.1007/s10534-011-9496-4
Kupeli E, Tatli II, Akdemir ZS, Yesilada E (2007) Estimation of antinociceptive and anti-inflammatory activity on Geranium pratense subsp. finitimum and its phenolic compounds. J Ethnopharmacol 114(2):234–240
Lian S, Su H, Zhao BX, Liu WY, Zheng LW, Miao JY (2009) Synthesis and discovery of pyrazole-5-carbohydrazide N-glycosides as inducer of autophagy in A549 lung cancer cells. Bioorg Med Chem 17(20):7085–7092. doi:10.1016/j.bmc.2009.09.004
Liu XH, Rose DP (1996) Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 56(22):5125–5127
Liu W, Zhou J, Bensdorf K, Zhang H, Liu H, Wang Y, Qian H, Zhang Y, Wellner A, Rubner G, Huang W, Guo C, Gust R (2011) Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives. Eur J Med Chem 46(3):907–913. doi:10.1016/j.ejmech.2011.01.002
Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444. doi:10.1038/nature07205
Maurin C, Bailly F, Cotelle P (2004) Improved preparation and structural investigation of 4-aryl-4-oxo-2-hydroxy-2-butenoic acids and methyl esters. Tetrahedron 60(31):6479–6486
Muller-Decker K, Kopp-Schneider A, Marks F, Seibert K, Furstenberger G (1998) Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2. Mol Carcinog 23(1):36–44. doi:10.1002/(SICI)1098-2744(199809)23:1<36:AID-MC5>3.0.CO;2-F
Nagarapu L, Mateti J, Gaikwad HK, Bantu R, Sheeba Rani M, Prameela Subhashini NJ (2011) Synthesis and anti-inflammatory activity of some novel 3-phenyl-N-[3-(4-phenylpiperazin-1yl)propyl]-1H-pyrazole-5-carboxamide derivatives. Bioorg Med Chem Lett 21(14):4138–4140. doi:10.1016/j.bmcl.2011.05.105
Nakanishi M, Gokhale V, Meuillet EJ, Rosenberg DW (2010) mPGES-1 as a target for cancer suppression: a comprehensive invited review “Phospholipase A2 and lipid mediators”. Biochimie 92(6):660–664. doi:10.1016/j.biochi.2010.02.006
Nitulescu GM, Draghici C, Missir AV (2010) Synthesis of new pyrazole derivatives and their anticancer evaluation. Eur J Med Chem 45(11):4914–4919. doi:10.1016/j.ejmech.2010.07.064
Okun R, Liddon SC, Lasagna L (1963) The effects of aggregation, electric shock, and adrenergic blocking drugs on inhibition of the “writhing syndrome”. J Pharmacol Exp Ther 139:107–109
Pavao-de-Souza GF, Zarpelon AC, Tedeschi GC, Mizokami SS, Sanson JS, Cunha TM, Ferreira SH, Cunha FQ, Casagrande R, Verri WA Jr (2012) Acetic acid- and phenyl-p-benzoquinone-induced overt pain-like behavior depends on spinal activation of MAP kinases, PI(3)K and microglia in mice. Pharmacol Biochem Behav 101(3):320–328. doi:10.1016/j.pbb.2012.01.018
Pereg D, Lishner M (2005) Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer. J Intern Med 258(2):115–123. doi:10.1111/j.1365-2796.2005.01519.x
Radmark O, Samuelsson B (2010) Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer. J Intern Med 268(1):5–14. doi:10.1111/j.1365-2796.2010.02246.x
Romano M, Claria J (2003) Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J 17(14):1986–1995. doi:10.1096/fj.03-0053rev
Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99(9):2254–2259. doi:10.1172/JCI119400
Sobolewski C, Cerella C, Dicato M, Ghibelli L, Diederich M (2010) The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol 2010:215158. doi:10.1155/2010/215158
Totzke G, Schulze-Osthoff K, Janicke RU (2003) Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition. Oncogene 22(39):8021–8030. doi:10.1038/sj.onc.1206837
Verri WA Jr, Cunha TM, Magro DA, Domingues AC, Vieira SM, Souza GR, Liew FY, Ferreira SH, Cunha FQ (2008) Role of IL-18 in overt pain-like behaviour in mice. Eur J Pharmacol 588(2–3):207–212. doi:10.1016/j.ejphar.2008.04.010
Vinegar R, Schreiber W, Hugo R (1969) Biphasic development of carrageenin edema in rats. J Pharmacol Exp Ther 166(1):96–103
Wang D, Dubois RN (2010) Eicosanoids and cancer. Nat Rev Cancer 10(3):181–193. doi:10.1038/nrc2809
Wei F, Zhao BX, Huang B, Zhang L, Sun CH, Dong WL, Shin DS, Miao JY (2006) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2′-hydroxy-3′-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate. Bioorg Med Chem Lett 16(24):6342–6347. doi:10.1016/j.bmcl.2006.09.008
Werz O, Schneider N, Brungs M, Sailer ER, Safayhi H, Ammon HP, Steinhilber D (1997) A test system for leukotriene synthesis inhibitors based on the in vitro differentiation of the human leukemic cell lines HL-60 and Mono Mac 6. Naunyn Schmiedebergs Arch Pharmacol 356(4):441–445
Wun T, McKnight H, Tuscano JM (2004) Increased cyclooxygenase-2 (COX-2): a potential role in the pathogenesis of lymphoma. Leuk Res 28(2):179–190
Xia Y, Dong ZW, Zhao BX, Ge X, Meng N, Shin DS, Miao JY (2007) Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells. Bioorg Med Chem 15(22):6893–6899. doi:10.1016/j.bmc.2007.08.021
Xia Y, Fan CD, Zhao BX, Zhao J, Shin DS, Miao JY (2008) Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells. Eur J Med Chem 43(11):2347–2353. doi:10.1016/j.ejmech.2008.01.021
Xie YS, Pan XH, Zhao BX, Liu JT, Shin DS, Zhang JH, Zheng LW, Zhao J, Miao JY (2008) Synthesis, structure characterization and preliminary biological evaluation of novel 5-alkyl-2-ferrocenyl-6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives. J Organomet Chem 693(7):1367–1374
Zheng LW, Wu LL, Zhao BX, Dong WL, Miao JY (2009) Synthesis of novel substituted pyrazole-5-carbohydrazide hydrazone derivatives and discovery of a potent apoptosis inducer in A549 lung cancer cells. Bioorg Med Chem 17(5):1957–1962. doi:10.1016/j.bmc.2009.01.037
Zheng LW, Li Y, Ge D, Zhao BX, Liu YR, Lv HS, Ding J, Miao JY (2010) Synthesis of novel oxime-containing pyrazole derivatives and discovery of regulators for apoptosis and autophagy in A549 lung cancer cells. Bioorg Med Chem Lett 20(16):4766–4770. doi:10.1016/j.bmcl.2010.06.121
Acknowledgments
This investigation was supported by a Scientific Research Grant 02/2010-20 awarded by Gazi University BAP. The authors greatly acknowledge D. A. Alkan (Department of Pharmacology) for her assistance for performing in vivo biological experiments. The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Çalışkan, B., Yılmaz, A., Evren, İ. et al. Synthesis and evaluation of analgesic, anti-inflammatory, and anticancer activities of new pyrazole-3(5)-carboxylic acid derivatives. Med Chem Res 22, 782–793 (2013). https://doi.org/10.1007/s00044-012-0072-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-012-0072-4